Sunday, November 1, 2026

HJ Shipbuilding Expands MRO Contracts With U.S. Navy: What’s Behind the Additional Maintenance Deals?

U.S. Navy officials praised HJ Shipbuilding's MRO capabilities during their visit, requesting additional maintenance beyond the original contract.

VIVIZ Rocks Atlanta: K-Pop Sensation Kicks Off North American Tour

South Korean K-pop girl group known as VIVIZ has announced a successful start to their North American tour.

How New Law Will Transform Human-Derived Fat into High-Value Bio-Materials

Human-derived fat, once medical waste, is now a valuable resource for biotech after new legislation allows its recycling for regenerative medicine.

Health

Unlock Your Health: Discover the New AI-Powered BioAge and Health Coach Services from DaNaA Data

Daewoo Group's AI health data firm, DaNaA Data, launched a service analyzing biological age, disease risk, and health check results.

How the New Medical School in Namwon Can Transform Regional Healthcare: Insights from Lawmaker Park Ji-won

Defining school locations alone won't solve local healthcare issues; deeper strategies are needed for effective solutions.

Ardens Lifescience Triumphs: How a Korean Startup Won 175,000 USD at MedTech Innovator APAC 2026

Adenz Life Sciences wins a global medical device competition, earning a prize of 175,000 USD.

Unlocking the Future of Healthcare: Daewoong’s AI-Powered Smart Hospital at AI EXPO MARS 2026

Daewoong Pharmaceutical introduces an AI-based smart hospital model for monitoring, diagnosis, testing, and rehabilitation.

10 Years of Excellence: Seoul’s APLAR Center Hosts International Rheumatology Training for Young Specialists

Seoul St. Mary's Hospital's Rheumatology Center held an international training program for foreign experts on October 27 and 26.

International Pharmaceutical Launches Exduo Plus – The New Triple-Combination Hypertension Treatment for 2026

International Pharmaceutical launches a new hypertension treatment combining three ingredients, expanding its cardiovascular product line.

Samsung Bioepis, Built on Biosimilars, Expands Growth Strategy Into Novel Drugs

Samsung Bioepis is pursuing a two-track growth strategy that combines global biosimilar expansion with next-generation novel drug development, including ADC therapies.

Shouting and flailing in your sleep? MRI may help identify patients at high risk for Parkinson’s

Neuromelanin-sensitive MRI may help identify REM sleep behavior disorder patients at higher risk of Parkinson’s disease who should undergo further PET evaluation.

Single-Port Robotic Surgery Shows Strong Results for Upper Tract Urothelial Cancer, Cuts Operating Time by 52 Minutes

A Seoul St. Mary’s Hospital study found that single-port robotic retroperitoneal surgery for upper tract urothelial cancer shortened operating time by 23.5%, reduced blood loss and showed comparable oncologic safety to conventional multi-port surgery.

Kangstem Biotech CSO Professor Kang Kyung-sun Confirms Therapeutic Potential of Vascularized Artificial Liver

Kangstem Biotech’s CSO Professor Kang Kyung-sun developed a vascularized artificial liver that showed therapeutic effects in animal models, offering potential for future transplant alternatives.

Beyond Approval to Insurance Coverage: Medical AI Companies Turn to Real-World Evidence to Drive Adoption

The focus of the medical AI industry is shifting from technology development to integration in healthcare settings.

Coreline Soft Wins German Lung Cancer Screening Project With 10-Year Long-Term Operating Contract

Coreline Soft is expanding its European AI medical imaging business through a 10-year German lung cancer screening contract, strengthening its position in the growing LDCT screening market.

Samsung Seoul, Asan Medical Center, Korea University Guro Rated Among ‘Best’ in Newsweek’s Green Hospital Ranking

Four South Korean hospitals earned Newsweek’s top five-leaf rating in its inaugural global ranking of the world’s greenest hospitals, highlighting the country’s growing focus on sustainable health care.

Unlocking Growth: How Biopharmaceuticals’ Cenobamate is Transforming Epilepsy Treatment in Asia

SK Biopharmaceuticals' epilepsy drug Cenobamate is expected to continue its growth trend in the second half of the year.

Drinking to Cope With Emotional Pain May Raise Depression Risk: “Only Harms Your Health”

Drinking to cope with trauma may worsen depression over time by weakening the brain’s ability to regulate stress.

AI to Fill Gaps in Regional and Essential Healthcare, Raising Hopes for a Major Shift in the Medical Device Market

South Korea's new AI healthcare strategy is expected to accelerate adoption of AI across public and essential healthcare, creating new growth opportunities for medical AI, healthcare IT and AI drug development companies.

How the SIALAP System Revolutionizes Preclinical Trials for Drug-Resistant Epilepsy

Researchers developed an objective framework for matching animal models to specific types of drug-resistant epilepsy, potentially improving the accuracy of preclinical drug development.

Is Your Food Safe? 5 Key Insights on Rising Salmonella and Norovirus Cases

Salmonella food poisoning has increased for five consecutive years, with nearly 10,000 cases reported last year.

Unlocking Gut Health: HP7 Probiotics vs. Postbiotics – What You Need to Know

Hy published research on its patented probiotic HP7 in the prestigious SCI journal JMB, highlighting its significance in gut health.

Top News

- Our Sponsors Ad -

Follow us